Shire's Pending Acquisition

Shire raised a round of funding on April 25, 2018. Investors include Takeda Pharmaceutical.

Shire (NASDAQ: SHPG) is a global biotechnology company that focuses on developing and delivering treatments for patients with rare diseases and other specialty conditions.…

Articles about Shire's Pending Acquisition: